India recorded highest surge in the second wave of coronavirus in between the Indian government has rolled out the vaccination drive for everyone above the age of 18 years of age.
At a time like this, there is a shortage of vaccines in the country. Indian vaccine manufacturer Serum Institute of India’s (SII) chief executive Adar Poonawalla has said that the shortage of vaccine is likely to remain till July. According to him, the authorities did not expect the second wave back in January as the Coronavirus cases were on a decline.
Poonawalla said that the production of the vaccines is expected to increase from 60-70 million doses (6-7 crore) to 100 million (10 crore) by July. He also said that his company has been slandered by politicians and critics over shortages in vaccines. He said that the government, not the Serum Institute, was responsible for policy decisions.
During the second wave, the firm has been under scrutiny for vaccine shortage. As SII came under the lens and is being blamed for the vaccine shortage, the company CEO has moved to the UK for the time being. Poonawalla also said that the vaccine’s production is going on in full swing in Pune, where SII’s factory is and he will be reviewing operations when he returns to India in a few days.